Biotech Wednesday: Joining forces to outsmart cancer – new frontiers in cell therapyHollandBIO
November 20th, Oncode and HollandBIO are joining forces to explore new frontiers in cell therapy to outsmart cancer.
Are you curious what the future of cell therapies has in store for us? And are you eager to learn from and connect with top-notch academics, clinicians and entrepreneurs from this field? Mark November 20th in your agenda and sign up below.
Prof. dr. Ton Schumacher – professor of molecular oncology and immunology at the Netherlands Cancer Institute (AVL)
Prof. dr. Sjoerd van der Burg – professor of immunotherapy, head experimental cancer immunology and therapy, head research laboratories medical oncology at LUMC
Dr. Sarah Derks – Medical oncologist at Amsterdam UMC
Troels Jordansen – CEO Glycostem
Dr. Albert van Hell – Medical Lead Cell & Gene Therapy NL at Novartis
Date: November 20th
Time: 12.30-18.00hr, including a networking lunch and drinks
Venue: Muntgebouw, Utrecht
Seats are limited, so make sure to reserve your spot for our Biotech Wednesday here.
HollandBIO members and employees of non-profit organisations can register for free (max 3 delegates per organisation). Non-HollandBIO members pay a registration fee of €75,- Euro (excl. VAT).